Wegovy8 min read7 September 2026

Wegovy pill: is oral Wegovy available in the Netherlands yet?

You have read that Wegovy is also coming as a pill and you want to know whether that is already possible: does the tablet exist, can you get it in the Netherlands and how does it compare with the injection and with Rybelsus?

Three white tablets on a stone saucer next to a glass of water on a light table in warm daylight

Is the Wegovy pill available in the Netherlands yet?

The Wegovy pill is licensed in Europe, but as of 22 September 2026 it is not yet routinely available in Dutch pharmacies. Since 2026, the European Medicines Agency (EMA) has listed Wegovy as the "first oral GLP-1 treatment for weight management", with tablets for adults alongside the prefilled pens.

Licensing and availability are two separate steps. After the European authorisation, the manufacturer decides per country when the medicine comes onto the market, and in the Netherlands the price and reimbursement assessment follows. A doctor can only prescribe the tablet once a Dutch pharmacy can supply it. We check this status periodically and update the date at the top.

Below you can read what the Wegovy pill is exactly, how it compares with Rybelsus and the injection, what is known about side effects, when it is coming to the Netherlands, why you need to be careful with online sellers right now and what to do if you are afraid of needles. Read more about Wegovy vs Saxenda. Read more about Wegovy dosage.

What exactly is the Wegovy pill?

The Wegovy pill is a tablet containing semaglutide, the same active substance as in the Wegovy injection, Ozempic and Rybelsus. According to the Wegovy product information, there are four strengths: 1.5, 4, 9 and 25 mg. You start with 1.5 mg per day and, after at least 4 weeks each time, increase to 4, 9 and eventually 25 mg, the maintenance dose.

You take the tablet once a day, whole, with a sip of water of no more than half a glass. You may not take more than one tablet a day, not even to mimic a higher dose. Because semaglutide is poorly absorbed through the stomach, the dose in milligrams is much higher than with the injection (25 mg per day compared with 2.4 mg per week); the amount that reaches your body is comparable.

What the Wegovy brand is and who it is licensed for is on the overview page. Important to know: Qlinic does not offer Wegovy. This article is intended as an explanation, not as an offer.

Wegovy pill, Rybelsus and the injection compared

All three contain semaglutide, but they differ in licensing, dose and use. Rybelsus is the existing semaglutide tablet, licensed for type 2 diabetes; the Wegovy tablet is licensed for weight management and has a higher maintenance dose.

Wegovy injectionWegovy tabletRybelsus tablet
Active substancesemaglutidesemaglutidesemaglutide
Licensed forweight management (adults and adolescents aged 12 and over)weight management (adults)type 2 diabetes
Dosage0.25 to 2.4 mg (or 7.2 mg) per week1.5, 4, 9 and 25 mg per day1.5, 4 and 9 mg per day (previously 3, 7 and 14 mg)
How to take itweekly injection, with or without fooddaily, on an empty stomach, half a glass of waterdaily, on an empty stomach, half a glass of water
Available in the Netherlandsyes, on prescriptionlicensed in Europe; not yet routinely in pharmacies (status 22-09-2026)yes, on prescription

The Rybelsus strengths were renewed in early 2026 (1.5, 4 and 9 mg replace 3, 7 and 14 mg). What that tablet does and who it is intended for is covered in the article on Rybelsus, the Ozempic pill.

Side effects of Wegovy tablets: what is known?

The side effects of the Wegovy tablet resemble those of the injection: mainly nausea, vomiting, diarrhoea and constipation, usually during the build-up phase. In the OASIS 4 study, published in The New England Journal of Medicine, 74 percent of participants on the tablet reported gastrointestinal symptoms, compared with 42 percent on placebo.

In that same study, participants with overweight or obesity lost an average of 13.6 percent of their body weight in 64 weeks with the 25 mg tablet, compared with 2.2 percent on placebo, in combination with lifestyle support. That is an average from a controlled study; results vary from person to person.

The rare serious side effects are the same as for all semaglutide medicines: inflammation of the pancreas, gallstones and the very rare eye condition NAION. Because absorption through the stomach varies more than with an injection, the effect can vary slightly more from day to day. The full overview is in the article on Wegovy side effects.

When is the Wegovy pill coming to the Netherlands?

As of 22 September 2026, no exact date for the Dutch market is known. The European licence is in place; the manufacturer has announced that it will introduce the tablet in the first markets outside the United States in the second half of 2026. Whether the Netherlands is one of them, and at what price, has not yet been decided.

Do not count on reimbursement: the Wegovy injection is not covered by basic health insurance (basisverzekering) when used for weight loss, and no different decision is known for the tablet. How reimbursement of Wegovy works is covered in the article on whether Wegovy is covered by insurance; the pharmacy prices of the injection are in the article on the Wegovy price.

Want to lose weight with medication, but not sure which form suits you? The doctor assesses whether medical weight loss is right for you and which medicine fits your situation best. Read more about medical weight loss with injections →

Buying Wegovy pills: why you need to be careful right now

As long as the Wegovy tablet is not available through Dutch pharmacies, any website selling "Wegovy pills" is by definition unreliable. The Inspectie Gezondheidszorg en Jeugd (IGJ, the Dutch Health and Youth Care Inspectorate) warns against fake online pharmacies that offer prescription medicines without a prescription: the products often contain too much, too little or no active substance, and a wrong dose can be life-threatening.

Even once the tablet is available, the route remains the same as for any semaglutide medicine: a doctor assesses you, writes a prescription, and a registered Dutch pharmacy supplies it. With an online seller, always check for the EU logo and the government register aanbiedersmedicijnen.nl. How the legal route works for Wegovy is covered in the article on how to buy Wegovy.

Which weight loss pills can you get through a doctor now?

At the moment there are two tablets in the Netherlands that a doctor can prescribe for overweight: Rybelsus (semaglutide, licensed for type 2 diabetes, off-label for weight loss) and Mysimba (naltrexone with bupropion, licensed for weight management). In addition, orforglipron, a non-peptide GLP-1 tablet, is in development.

Whether a tablet suits your situation is for the doctor to assess: taking it daily on an empty stomach, the variable absorption and your medical background all play a part. An overview of what is coming is in the article on new weight loss drugs.

Afraid of needles? These are your options

Fear of needles is a common reason to look for a pill, but in practice most people find the weekly injection easier than expected. The needle is short and thin, the injection goes into the fat under the skin of the abdomen or thigh and takes a few seconds. Many users who dreaded injecting beforehand call it routine after two weeks.

If the hurdle stays too high, discuss it with the doctor. They can do the first injection with you, show you the technique and assess whether a tablet is an alternative. With a medical weight loss programme with injections, that support is part of the start.

Tried everything and wondering whether a medical programme is right for you? A few questions show you where you stand, and the doctor then assesses your situation. Take the eligibility check →

Frequently asked questions about the Wegovy pill

What is the Wegovy pill?

A tablet containing semaglutide in strengths of 1.5, 4, 9 and 25 mg, taken once a day on an empty stomach, licensed in the EU for weight management in adults. It is the tablet form of the Wegovy injection.

What is the difference between Ozempic and Wegovy?

Both contain semaglutide. Ozempic is licensed for type 2 diabetes (up to 2 mg per week), Wegovy for weight management (up to 2.4 mg or 7.2 mg per week, and now also as a tablet). The comparison is in the article on Wegovy vs Ozempic.

What is an alternative to Wegovy?

Other GLP-1 medicines: Ozempic (semaglutide), Mounjaro (tirzepatide) and Saxenda (liraglutide) as an injection, Rybelsus as a tablet. Which medicine suits you is a decision for the doctor, based on your health and your response to the medication.

What are the new weight loss pills?

The Wegovy tablet (semaglutide 25 mg) is the first GLP-1 pill for weight management in the EU. Orforglipron is in development. Rybelsus has been around for longer, but is licensed for type 2 diabetes.

Is Ozempic in pill form effective?

Rybelsus, the tablet form of semaglutide, lowers blood sugar and leads to weight loss, but it has been studied at lower doses than the Wegovy tablet. In OASIS 4, the 25 mg tablet gave an average weight loss of 13.6 percent in 64 weeks; results vary from person to person. Read more about Wegovy reviews.

How much will the Wegovy pill cost?

That is not yet known for the Netherlands. Once the tablet is in pharmacies, the price will be listed on medicijnkosten.nl, the website of Zorginstituut Nederland (the Dutch National Health Care Institute). Reimbursement when used for weight loss is not expected.

<!-- klant:eind -->

Responsible for this information: Qlinic B.V., Markenhaven 25A, Amersfoort. Published: 7 September 2026. This article is general information and does not replace personal medical advice.

Dokter Naas (Nazanin Ahmadi Mozafari), BIG-registered doctor at Qlinic

About the author

Nazanin Ahmadi Mozafari

Doctor · BIG 59925559301

Guides you from intake to follow-up and knows your file, no changing faces.

More about Nazanin Ahmadi Mozafari